Objectives
To quantify trends in pediatric computed tomography (CT) use and
associated radiation exposure and cancer risk.
Design
Retrospective observational study.
Setting
Seven US healthcare systems.
Participants
CT use was evaluated in children <15 years from 1996-2010,
including 4,857,736 child-years of observation. Radiation doses were
calculated for 744 CT scans performed between 2001-2011.
Outcome Measures
Rates of CT use, organ and effective doses, and projected lifetime
attributable cancer risks.
Results
CT use doubled in children <5 years and tripled in children
5-14 between 1996-2005, stabilized until 2007, then declined. Effective
doses varied from 0.03-69.2mSv per scan. An effective dose of ≥20mSv
was delivered by 14-25% of abdomen/pelvis CTs, 6-14% of spine CTs, and 3-8%
of chest CTs. Projected lifetime attributable risks of solid cancer were
higher in younger patients and girls, and for abdomen/pelvis and spine CTs.
In girls, a radiation-induced solid cancer is projected to result from every
300-390 abdomen/pelvis CTs, 330-480 chest CTs, and 270-800 spine CTs,
depending on age. Leukemia risk was highest for head CTs in children
<5 at 1.9/10,000. Nationally, 4 million pediatric CTs of the head,
abdomen/pelvis, chest, or spine performed each year are projected to cause
4870 future cancers. Reducing the highest 25% of doses to the median might
prevent 43% of these cancers.
Conclusions
Increased use of pediatric CT combined with wide variability in
radiation doses has resulted in many children receiving a high-dose
examination. Dose-reduction strategies targeted to the highest quartile of
doses could dramatically reduce the number of radiation-induced cancers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.